UniXell Biotechnology doses first Parkinson’s patient with iPSCs, reports improvements
The Chinese biotech company reports that the patient showed notable improvements in sleep quality and motor function, with no serious adverse events.
Neurology
Trailhead Biosystems launches iPSCs for blood-brain barrier and neurological research
Researchers may now have a new tool to unlock insights into blood-brain barrier regulation and neurological disease mechanisms.
TreeFrog Therapeutics nabs €30M in funding to accelerate its iPSC technology, planning Parkinson’s trial in 2027
TreeFrog has developed a proprietary iPSC manufacturing process called C-Stem, moving one step closer to human trials.
Stem cell exosomes for spinal cord injury: Preclinical study shows improved motor function and blood flow
NurExone Biologic's exosome product moves one step closer to clinical trials with their latest data, published in Cyotherapy.
Parkinson’s stem cell trial launches: Aspen Neuroscience doses first patient with iPSCs
A new milestone for iPSC therapy in the USA, this is one to watch.
New Study: Intrathecal Umbilical Stem Cells + Transcutaneous Stimulation for Spinal Cord Injury
The neurorehabilitation hospital in Spain will investigate if allogeneic umbilical-derived stem cell therapy can help enhance recovery.
iPSC-Derived Motor Neuron Cells’ Dose Escalation Trial for Subacute Spinal Cord Injury, a Phase I
This study will evaluate if allogeneic human induced pluripotent stem cell (iPSC)-derived motor neuron progenitor cells (XS228, made by XellSmart) can safely and effectively treat subacute spinal cord injury. Researchers at the...
ALS Stem Cell Trial: Efficacy and Safety of NurOwn in Early & Moderate ALS (ENDURANCE STUDY)
Brainstorm Therapeutics is back, and they've learned a lot from their previous trials. If you don't know the history of Nurown, their ALS stem cell candidate, it showed early promise in Phase...
Lineage Cell Therapeutics’ Spinal Cord Injury Stem Cell Trial, New Delivery Device
The new DOSED trial will explore a novel delivery method for OPC1 cells, potentially bringing hope to chronic SCI patients.
Stem cell trial for early Alzheimer’s disease to begin at UTHealth Houston, will use Hope Biosciences’ technology
Will adipose stem cell therapy hold an answer for neuroinflammation, a factor in Alzheimer's?
